类风湿关节炎中针对环瓜氨酸化II型胶原肽的自身抗体反应
该研究采用珠基多重检测法,在中国RA队列(415例RA、304例OA及203例健康人)中检测针对54种环化17-mer瓜氨酸化CII肽及对应未修饰肽的自身抗体。结果显示RA患者对环瓜氨酸化CII肽的抗体反应高于OA和健康人,对未修饰肽反应极低,并鉴定出多种新型瓜氨酸化CII表位,抗体反应呈异质性结合模式。
要点
- RA患者对环瓜氨酸化CII肽的自身抗体反应高于OA患者和健康人。
- 对环化未修饰CII肽的抗体反应极低或可忽略。
- 鉴定出多种新型瓜氨酸化CII表位,抗体反应存在重叠及独特特异性。
核心结论
- 在中国RA队列血清中,针对环瓜氨酸化CII的自身抗体呈高流行率。
- 研究揭示针对新型瓜氨酸化CII表位的异质性结合模式,可能有助于将RA患者分层为不同亚组。
研究设计与样本
- 采用珠基多重检测法,检测415例RA患者和304例OA患者对54种环化17-mer瓜氨酸化CII肽及对应未修饰肽的抗体。
- 另在203例健康个体中检测针对选定10种环化瓜氨酸化肽的自身抗体反应。
主要发现
- RA患者对环瓜氨酸化CII肽的自身抗体反应高于OA患者或健康个体。
- 对环化未修饰CII肽的抗体反应极少或可忽略。
- 鉴定出多种新型瓜氨酸化CII表位,其抗体反应既有 substantial 重叠反应性,也有独特特异性。
临床怎么用
- 针对环瓜氨酸化CII肽的自身抗体检测可能有助于RA的血清学评估。
- 新型瓜氨酸化CII表位的异质性结合模式或可用于RA患者亚组分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The detection of anti-citrullinated peptide antibodies (ACPAs) is a serological hallmark of RA. Autoantibodies reactive with collagen type II (CII) are present in RA sera and synovial fluid and are potentially pathogenic. Here, we investigate the prevalence and specificity of the autoantibody responses to defined citrullinated cyclic peptides derived from CII in a China RA cohort. METHODS: Using bead-based multiplex assay, we examined the presence of autoantibodies binding to 54 cyclic 17-mer citrullinated CII peptides, encompassing all citrullinate epitopes in CII, and the corresponding unmodified peptides in 415 RA patients, in addition to 304 patients with OA. Furthermore, the autoantibody responses to a selected set of 10 cyclic citrullinated peptides were also examined in 203 healthy individuals. RESULTS: Autoantibody responses to cyclic citrullinated CII peptides were higher in RA patients as compared with OA patients or healthy individuals, whereas little or negligible antibody responses to cyclic unmodified CII peptides were observed. Interestingly, several novel citrullinated CII epitopes were identified. Antibodies to these novel citrullinated CII epitopes showed not only substantial overlapping reactivities but also had unique specificities. CONCLUSION: We found a high prevalence of autoantibodies against cyclic citrullinated CII in the sera of patients in a China RA cohort. The present study revealed heterogeneous binding patterns against novel citrullinated CII epitopes, which may help to stratify RA patients into different subgroups.
引用
- Liang B, Ge C, Lönnblom E, et al. The autoantibody response to cyclic citrullinated collagen type II peptides in rheumatoid arthritis. Rheumatology (Oxford). 2019. PMID: 30892636. doi:10.1093/rheumatology/kez073
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。